📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. (2013)

First Author: Anderson RA

Attributed to: A Constraint Solver Synthesiser funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2013.07.014

PubMed Identifier: 23968732

Publication URI: http://europepmc.org/abstract/MED/23968732

Type: Journal Article/Review

Volume: 49

Parent Publication: European journal of cancer (Oxford, England : 1990)

Issue: 16

ISSN: 0959-8049